Little is known about the growth-signaling pathways that govern the proliferation of Ewing tumor (ET) cells either in vitro or in vivo. We have studied signal transduction pathways in ET cell lines and compared kinase expression levels and proliferation rates with primary tumors. Cell lines were studied both as conventional adherent monolayers and as anchorage-independent multi-cellular spheroids. Importantly, we observed signi®cant dierences between these in vitro models and found that ET spheroids were more closely related to primary tumors with respect to cell morphology, cell ± cell junctions, proliferative index and kinase activation. Monolayer ET cells demonstrated serum-dependent phosphorylation of ERK1/2 and AKT and constitutively high serum-independent cyclin D1 protein expression. However, when ET cells were placed in suspension culture, there was immediate serum-independent activation of ERK1/2 and AKT. In addition, cyclin D1 protein expression was completely blocked until stable multicellular spheroids had formed, indicating that cell ± cell adhesion is necessary for the proliferation of anchorage independent ET cells. This reduction in cyclin D1 expression was post-transcriptional and could be mimicked in monolayer cells by treatment with phosphatidyl inositol-3 kinase (PI3K) inhibitors. Moreover, PI3K inhibition signi®cantly reduced ET cell proliferation and, in primary ET samples, cyclin D1 expression correlated with expression of activated AKT. Thus, the PI3K ± AKT pathway appears to be critical for the proliferation of ET cells both in vitro and in vivo and tumor cell growth in vivo may be better represented by the study of anchorage-independent multi-cellular spheroids.
Introduction
The Ewing family of tumors (ET) comprise a group of histologically diverse, genetically related lesions whose cell of origin is likely a pluripotent neural stem cell (Triche, 1993) . ET occurs primarily in late childhood and adolescence, aecting either bone or soft tissue as primary sites with frequent metastatic disease observed in bone marrow and lungs. Genetically, virtually all members of the ET family are characterized by the presence of a novel fusion gene resulting from chromosomal translocation between the EWS locus on chromosome 22q23 and various members of the ETS gene family, usually either the FLI1 gene on chromosome 11q22 or the ERG gene on chromosome 21q22 (Delattre et al., 1992; Sorensen et al., 1994) . Resultant EWS ± ETS chimeric proteins are oncogenic and have potent transformation activity in murine NIH-3T3 cells (May et al., 1993) . The mechanism of oncogenic transformation induced by EWS ± ETS fusions is not clearly understood but is thought to involve aberrant transcription of normal ETS target genes and possible facilitation of passage through the cell cycle.
Despite the extensive genetic characterization of this malignancy, relatively little is known about the signaling pathways that govern the growth and survival of ET cells. Recently, basic ®broblast growth factor (bFGF) has been implicated in the maintenance of the malignant phenotype (Girnita et al., 2000) , and Silvany et al. (2000) have reported a correlation between ERK1/ERK2 activation and EWS-FLI1-dependent transformation. Several potential autocrine growth factor loops have also been described. The presence of an intact insulin-like growth factor type I receptor (IGFRI) appears to be essential for transformation by EWS ± ETS proteins and this receptor may function in survival and/or mitogenic signaling in ET (Scotlandi et al., 1996; Toretsky et al., 1997; Yee et al., 1990) . We have reported that the mammalian homologue of bombesin, gastrin releasing peptide (GRP), functions as an autocrine growth factor in these tumors (Lawlor et al., 1998) . The signal transduction cascades initiated in ET in response to these growth factors and to EWS ± ETS fusion proteins themselves remain to be elucidated, but both the RAS ± RAF1 ± MEK ± ERK1/2 mitogen-activated protein kinase (MAPK) pathway and the phosphatidyl inositide-3-kinase (PI3K) ± AKT pathway are likely candidates given the reported essential roles of these cascades in malignant transformation. While the PI3K ± AKT pathway was formerly thought to provide primarily a cell survival signal, it now appears that this pathway, via complex mechanisms that are incompletely understood, may complement the RAS ± RAF1 ± MEK ± ERK1/2 cascade in increasing expression of cyclin D and promoting the G1 to S phase transition (MuiseHelmericks et al., 1998; Roovers and Assoian, 2000; Scheid and Woodgett, 2000; Sherr, 2000) .
In traditional cell culture models of sarcomas and many other human solid tumors, cells are grown as adherent monolayers on plastic dishes in the presence of serum and other growth factors. However, among the in vitro features that dierentiate transformed cell cultures from those of normal cells are their decreased growth factor requirements and their ability to grow in an anchorage-independent environment (Ponten, 1971) . These properties likely correlate with the clinical features of malignant tumors; that is, the ability to in®ltrate surrounding tissues and to establish distant metastases (Baserga, 1997) . In an eort to better represent the anchorage independent in vivo setting of tumor cells, some investigators have utilized the three-dimensional spheroid cell culture model for studies of cancer cell biology. Spheroids are multicellular structures of intermediate complexity between in vivo tumors and monolayer cultures and, as such, may demonstrate biologic characteristics that are more closely related to those of primary tumors (Santini and Rainaldi, 1999) .
In this study we have investigated the roles of the RAS ± RAF1 ± MEK ± ERK and the PI3K ± AKT pathways in the regulation of cell proliferation in adherent monolayer and anchorage-independent spheroid ET cell cultures. Speci®cally, we have evaluated the respective roles of these pathways in the regulation of cyclin D1 expression and cell proliferation. Our results indicate that control of cyclin D1 in ET cells is largely post-transcriptional, is integrally linked to the PI3K ± AKT pathway, and varies considerably between monolayer and spheroid cultures. Moreover, we have found that the morphologic and biochemical characteristics of spheroid ET cells closely parallel those of primary tumors, suggesting that the spheroid model may be a more representative model in which to study ET growth signaling pathways in vitro.
Results
Ewing tumor cells spontaneously form spheroids when grown in suspension TC32, A4573 and 5838 are well-studied ET cell lines derived from primary tumors which have been shown to express EWS ± ETS gene fusions. TC32 and A4573 express 7/6 and 7/5 EWS ± FLI1 fusions, respectively, while 5838 expresses an EWS ± ERG fusion (Dunn et al., 1994; Whang-Peng et al., 1984; Yee et al., 1990) . To study growth under nonadherent conditions, con¯uent ET cell monolayers were trypsinized and placed as single cell suspensions in medium overlayed on agar-coated dishes (preventing attachment to plastic), and their growth characteristics monitored morphologically. All cell lines behaved in a similar fashion. Within 1 h of replating, the single cells began to form loose clumps Figure 1 ET cells form multi-cellular spheroids when grown in suspension. Adherent monolayer ET cells were grown to con¯uence, trypsinized, resuspended and then replated on agar-coated dishes at a density of 5610 6 cells/10 cm dish. Shown here are phase-contrast photomicrographs (6100) of TC32 cells after 1 ± 24 h in suspension in serum containing media. Similar results were observed for all ET cell lines studied (data not shown) that continued to increase in density over time. By 24 h almost no single cells remained and irregular shaped clumps were evolving into tight spheroidal structures (see Figure 1 ). Histologic analysis of hematoxylin and eosin (H&E) stained sections revealed round cell morphologies in ET spheroids that were virtually identical to those of primary ET (see Figure 2a) , in contrast to the spindle-shaped cells of adherent monolayers (Figure 2a) . Moreover, ultrastructural analysis of TC32 spheroids showed numerous well-developed tight junctions between neighbouring spheroid cells that were indistinguishable from those of primary ET, in contrast to the rare poorly-formed junctions observed in monolayer cultures (see Figure 2b ). The survival of ET cells in suspension was highly dependent on the formation of multi-cellular aggregates. If less than 0.5610 6 cells were initially plated in a 10 cm agar-coated dish, the vast majority of cells remained as single cells which were dead after 6 ± 12 h in suspension, as measured by Trypan blue exclusion (data not shown). Spheroids readily formed when cells were plated at higher densities (at least 1 ± 2610 6 cells/ plate), with almost 100% of clumped cells remaining viable after 24 h while single cells were dead.
Adherent monolayer ET cells have significantly higher rates of proliferation than either spheroid or primary tumor cells Several studies have reported proliferative rates ranging from 7 ± 14% for primary ET (de Alava et al., 2000; Mellin et al., 1989; Niggli et al., 1994; Scotlandi et al., 1995; Vollmer et al., 1989) . We used three dierent methods to determine the proliferative state of TC32 cells grown in monolayer or spheroid cultures. First, using an antibody to proliferating cell nuclear antigen (PCNA), which is a well-established marker of cells in S phase or mitosis (Kawamura et al., 2000) , we performed immunohistochemical analysis of ®xed monolayer and spheroid TC32 cells in addition to primary ET biopsy specimens. TC32 monolayer cells showed PCNA staining in a large majority of cells. In contrast, TC32 spheroids and the primary ET sections showed very similar staining patterns, with fewer than 10% of cells being PCNA positive (see Figure 3a) . Second, cell cycle was assessed using FACS analysis of DNA content in propidium iodide stained cells. Consistent with the Figure 4 Cyclin D1 protein expression is dependent on cell ± cell adhesion and serum stimulation in suspension cultures of ET cells. (a) Monolayer TC32 cells were starved for 24 h and then replated on agar-coated dishes at a density of 3 ± 5610 6 cells/10 cm dish, in either serum-free (left panel), 15% serum-containing medium (right panel), or in 15% serum with continuous rocking of the plates to prevent spheroid formation (right panel). Suspension cells were then collected at the indicated time-points and analysed for expression of cyclin D1 by Western analysis. Total AKT levels were used to demonstrate equal loading. (b) TC32 cells were grown in 15% serum on regular plates as monolayers or on agar-coated dishes for 48 h to form stable spheroids. Cells were then starved for 24 h in 0.25% serum, followed by treatment with (+) or without (7) 15% serum for the indicated times. Cyclin D1 levels were assessed by Western analysis as above. Total AKT levels were used to demonstrate equal loading. (c) 5838 and A4573 monolayer (ML) and stable spheroid cells grown in 15% serum-containing medium were starved for 24 h in 0.25% serum and then treated with (+) and without (7) serum for 3 h, prior to assessment of cyclin D1 levels as above. Grb2 levels were used to demonstrate equal loading PCNA results, we observed much higher proliferative rates in monolayer compared to spheroid cells and a marked decrease in the proliferative index of spheroids in response to serum starvation. After overnight serum-starvation, 46% of monolayer cells were still proliferating as compared to only 9% of spheroid cells. Twelve hours of serum stimulation increased these proliferative rates to 64 and 16%, respectively (Table 1) . Finally, cells were assessed for uptake of bromo-deoxyuridine (BrdU) as a measure of proliferation. As shown in Figure 3b ,c, the proliferative index of monolayer cells over a 20 h period was signi®cantly greater than spheroid cells and the latter were more responsive to serum stimulation. In keeping with FACS and PCNA data, 60% of serum-stimulated monolayers were proliferating compared to only 9% of serum-stimulated spheroid cells. Therefore, the proliferative index of ET spheroid cells is signi®cantly lower than monolayer cells and is much more in keeping with the proliferative rates of primary Ewing tumors in vivo.
Cyclin D1 protein expression in ET cells grown in suspension requires cell ± cell adhesion and is serum-dependent
We next wished to assess whether the observed dierences in proliferation were associated with dierences in cyclin D1 expression in ET monolayer and spheroid cells. Constitutive up-regulation of cyclin D1 has been described in numerous tumor types and is implicated in oncogenesis (reviewed in Sherr, 2000) . Monolayer TC32 cells demonstrated high levels of cyclin D1 expression that were independent of serum stimulation (see left panel, Figure 4a ). However, we observed immediate and virtually complete loss of cyclin D1 protein expression when cells were placed in suspension, either under high-serum or serum-free conditions (left and middle panels, Figure 4a ). Cyclin D1 expression slowly increased over time coincident with cell clumping but only when cells were suspended in serum-containing medium (middle panels, Figure  4a ). In contrast, cyclin D1 remained undetectable even in the presence of serum when suspended cells were prevented from clumping by continuous rocking of the cultures (see right panel, Figure 4a ). We also tested whether cyclin D1 expression remained serum-dependent once stable spheroids had formed. TC32 spheroids were grown as above for 48 h in the presence of serum, and then subjected to overnight serum starvation. This resulted in a marked loss of cyclin D1 protein which could be recovered by addition of serum to the medium (see right panel, Figure 4b ). These results indicate that in contrast to monolayer TC32 cells which are characterized by constitutive serum-independent cyclin D1 expression, anchorage-independent TC32 cells appear to require both serum stimulation and cell ± cell adhesion for cyclin D1 protein expression. Similar Figure 5 Dierential activation of the ERK1 and ERK2 MAP kinases and of AKT in ET monolayer and suspension cultures. Con¯uent ET cells were trypsinized and replated on regular or agar-coated dishes, allowed to grow for 48 h, and then starved for 24 h in 0.25% serum prior to stimulation with (+) or without (7) 15% serum for 30 min. For those cells that were in suspension for only 1 h, monolayer cells were starved for 24 h prior to being replated on agar-coated dishes for 1 h with or without serum. Cells were then lysed for Western analysis using phospho-speci®c antibodies. (a) Western blot analysis of TC32 whole cell lysates using an antibody that recognizes phosphorylated ERK1/2 (P-ERK1/2). Total ERK/2 levels were used to demonstrate equal loading. (b) Western analysis of TC32 whole cell lysates for expression of AKT phosphorylated at serine 473 (P-AKT). Total AKT levels were used to demonstrate equal loading. (c) Western analysis of 5838 and A4573 ET monolayer (ML) and spheroid cells treated identically as TC32 cells for the 48 h time-point, using the same a-P-ERK1/2 and a-P-AKT antibodies. Total Grb2 levels were used to demonstrate equal loading to TC32, monolayer cultures of the ET cell lines A4573 and 5838 also expressed high, serum-independent cyclin D1 expression while spheroid cultures of these cell lines had lower levels of expression which were serumresponsive (see Figure 4c ).
The ERK1/2 MAPK and PI3K ± AKT pathways are up-regulated in ET cells in suspension
We next assessed whether dierences in proliferation and cyclin D1 expression between monolayer and suspension ET cells were accompanied by dierences in mitogenic and cell survival signaling pathways. Constitutive activation of the MAP kinases ERK1 and ERK2 and the survival factor AKT have been implicated in the uncontrolled growth of numerous malignancies including ET (Hoshino et al., 1999; Silvany et al., 2000; Toretsky et al., 1999) . As shown in Figure 5a (left panel), starved TC32 monolayer cells responded to serum by markedly increasing levels of ERK1 and ERK2 phosphorylation. However, when these cells were placed in suspension as described above, both kinases immediately became activated in a serum-independent fashion (see right panel of Figure 5a ). This constitutive activation of ERK1/2 was sustained, being observed in stable spheroids that had been in suspension for 48 h or more (see Figure 5a) .
Screening for phosphorylation of AKT at serine residue 473 was used to assess activation of the PI3K-AKT pathway in TC32 cells. AKT phosphorylation was readily induced by serum in monolayer cells, but suspension of these cells resulted in AKT phosphorylation even in the absence of serum (see Figure 5b) . However, AKT phosphorylation in TC32 spheroids was only transiently serum-independent, in contrast to the sustained ERK1/2 activation described above. By 48 h, corresponding to the formation of stable spheroids, the basal level of AKT phosphorylation had decreased to that of monolayer cells and was again serum-inducible (see Figure 5b ). An identical pattern of phosphorylation of the other major AKT phosphorylation site, threonine 308, was observed (data not shown). As shown in Figure 5c (top panel), 5838 and A4573 spheroids showed similar increases in ERK activation relative to monolayer cultures. As with TC32, AKT activation was initially serumindependent (data not shown), but then became serum-responsive after longer-term stimulation (middle panel, Figure 5c ). Interestingly, basal levels of phosphorylated AKT were higher in A4573 spheroid cells compared with the other ET cell lines even in the absence of serum (Figure 5c ).
MEK inhibition does not appreciably affect cyclin D1 protein expression or cellular proliferation in ET cells
Activation of ERK1/2 and AKT have both been linked to induction of cyclin D1 (reviewed in Roovers and Figure 6 MEK1 inhibition has little eect on ET cell proliferation. (a) TC32 monolayers and stable spheroids were starved for 24 h in 0.25% serum and then treated with the MEK1 inhibitor U0126 or vehicle control. Following treatment, cells were incubated with (+) or without (7) serum for 30 min (+30') or 3 h (+3 h) prior to cell lysis. Western blot analysis was performed using phospho-ERK1/2 (P-ERK1/2) and cyclin D1 speci®c antibodies. (b) TC32 cells were grown for 20 h in BrdU containing media with or without U0126 and then analysed by immunohistochemistry for uptake of BrdU as a measure of proliferation. The percentage of positive cells is an average of ®ve high power ®elds (total of 1000 ± 2000 cells)+standard deviation Assoian, 2000) . We therefore wished to determine whether the observed variations in either of these pathways could explain the dierences in cyclin D1 levels found in ET monolayers versus spheroids. In TC32 monolayers, activation of ERK1/2 did not correlate with changes in cyclin D1 expression as the latter was already elevated whether or not serum (which induced ERK1/2 phosphorylation) was added to the cultures (see Figures 5a,b,c) . TC32 spheroids, despite demonstrating serum-independent (constitutive) ERK1/2 activation, remained dependent on serum for expression of cyclin D1 (see Figure 4) . Moreover, treatment of monolayer or spheroid TC32 cells with the MEK inhibitor U0126 resulted in decreased ERK1/ 2 phosphorylation but had no appreciable eects on cyclin D1 protein levels (see Figure 6a) . Therefore dierences in ERK1/2 activation do not appear to underlie the dierences in cyclin D1 regulation observed in TC32 spheroids versus monolayers.
To con®rm these ®ndings, we next determined if MEK inhibition altered the proliferative index of ET cells in culture. We therefore assessed TC32 monolayer and spheroid cells for uptake of bromo-deoxyuridine (BrdU) in the presence or absence of U0126. As shown in Figure 6b , monolayer cells incubated with the MEK inhibitor U0126 had only a slight reduction in their proliferative index while no signi®cant eect was observed in spheroid cells.
PI3K inhibition blocks cyclin D1 protein expression in ET cells and significantly reduces proliferation
We next evaluated the role of the PI3K ± AKT pathway in cyclin D1 regulation and cellular proliferation. Treatment of both monolayer and spheroid TC32 cells with the PI3K inhibitor LY294002 resulted in markedly reduced AKT phosphorylation and complete loss of cyclin D1 protein expression, which was independent of the presence of serum (see Figure 7a ). The block in cyclin D1 expression was sustained even after long term serum-stimulation of cells and similar ®ndings were observed with another PI3K inhibitor, wortmannin (data not shown). LY294002 treatment of A4573 ET cells resulted in a similar reduction of cyclin D1 protein levels, even though AKT phosphorylation was not completely blocked by this agent (Figure 7b) . Moreover, incubation of either monolayer or spheroid TC32 cells with LY294002 resulted in a marked reduction in cell proliferation as measured by BrdU uptake (Figure 7c ). Therefore, PI3K activation appears to be essential for cyclin D1 protein expression and cellular proliferation in both monolayer and spheroid cultures of ET cells.
Interestingly, we found that PI3K inhibition reproducibly led to serum-independent increases in ERK1/2 phosphorylation in TC32 monolayer cells. In fact, levels of phosphorylated ERK1/2 after LY294002 treatment were similar to those observed in untreated TC32 spheroids (compare P-ERK1/2 panels in Figure  7a ). This suggests potential cross-talk between PI3K ± AKT and RAS ± ERK1/2 pathways in ET cells, which we are currently evaluating in more detail. In spite of its dramatic eects on cyclin D1 expression, LY294002 did not appear to aect ERK1/2 activation in TC32 spheroids (see Figure 7a) , further underscoring the possibility that the PI3K ± AKT pathway may be more critical than ERK1/2 activation in regulating cyclin D1 levels in ET cells.
Primary Ewing tumors demonstrate patterns of cyclin D1 expression and ERK1/2 and AKT activation that resemble those of ET spheroids Given the dierences in cyclin D1 expression and activation of key signaling pathways that we observed between ET cell monolayers and spheroids, we sought to determine which culture condition more closely mim- icked ET growth in vivo. Seven fresh-frozen primary ET biopsy samples were obtained and total protein lysates were analysed as described above for monolayer and spheroid cultures. All samples were obtained prior to initiation of therapy and were positive for EWS-FLI1 gene fusions. Six cases expressed the most common EWS exon 7/FLI1 6 gene fusion while a single case (case 6) expressed an exon 10/5 fusion (reviewed in Zucman et al., 1993) (data not shown). As shown in Figure 8 , high levels of phosphorylated ERK1/2 were present in all of the primary tumor samples. Furthermore, AKT phosphorylation could be detected in six of the seven primary tumors. Cyclin D1 protein expression appeared to correlate with levels of AKT phosphorylation in these tumors, as low or undetectable levels of cyclin D1 were observed in several tumors even in the presence of high ERK1/2 phosphorylation (see lanes 1, 3 and 6 of Figure  8 ). Although the sample size is small, these results provide evidence that cyclin D1 expression of in vivo ET cells may be more closely linked to AKT rather than ERK activation, as was found for ET cell lines. Moreover, the pattern of ERK1/2 and AKT phosphorylation as well as cyclin D1 expression of the primary tumors was more in keeping with ET spheroids than monolayers, indicating that primary ET growth signaling in vivo may be better represented in vitro by anchorage-independent spheroid culture systems.
Regulation of cyclin D1 expression in spheroids is post-transcriptional but does not correlate with GSK3b phosphorylation
Cyclin D1 protein levels are tightly regulated by both transcriptional and post-transcriptional mechanisms (Muise-Helmericks et al., 1998; Shao et al., 2000; Sherr, 2000) . In order to assess whether the observed down-regulation of cyclin D1 protein in ET spheroids might be occurring through a transcriptional process, we performed Northern analysis of TC32 cell cultures using a cyclin D1 speci®c cDNA probe. We observed that cyclin D1 transcript levels were similar in monolayer and spheroid cells (data not shown). Moreover, neither serum starvation nor starvation followed by serum stimulation had an appreciable eect on cyclin D1 mRNA levels in either culture condition. This data suggests that regulation of cyclin D1 protein expression in ET cells may be largely posttranscriptional, at least in vitro. We also examined whether inhibition of ERK1/2 MAP kinase or PI3K ± AKT pathways aected cyclin D1 transcript levels. Again, Northern analysis revealed that neither MEK nor PI3K inhibition signi®cantly altered levels of cyclin D1 mRNA (data not shown). These results strongly support the presence of a post-transcriptional cyclin D1 regulatory pathway in ET cells.
Glycogen synthase kinase 3b (GSK3b) is known to regulate cyclin D1 expression by inhibiting gene transcription and through enhanced protein degradation, and these activities are inhibited by AKT phosphorylation of GSK3b at residue serine 9 (Diehl et al., 1998; Shao et al., 2000; van Weeren et al., 1998). We therefore compared the phosphorylation status of GSK3b in TC32 monolayers versus spheroids using an antibody directed against GSK3b (Ser 9) and found no dierences (data not shown). Therefore, the reduced cyclin D1 levels observed in ET spheroids cannot be explained on the basis of diminished GSK3b phosphorylation by AKT in these cells. Moreover, primary tumor samples expressed high levels of phosphorylated GSK3b despite dierences in levels of activated AKT or cyclin D (see Figure 8) . Interestingly, when we treated either monolayer or spheroid TC32 cells with PI3K inhibitors at levels which blocked AKT phosphorylation and cyclin D1 protein expression, there were still appreciable levels of phosphorylated GSK3b that could be further induced with serum (data not shown). This suggests that in ET cells there may be a PI3K ± AKT independent pathway contributing to GSK3b phosphorylation. Taken together, our ®ndings indicate that the eect of PI3K blockade on cyclin D1 levels in ET cells may be independent of GSK3b phosphorylation.
Discussion
Cell cycle progression of non-transformed cells is dependent on the coordinated control of cyclin ± cyclindependent kinase complexes as induced by growth factors as well as adherence to an extracellular matrix (Assoian, 1997) . In contrast, transformed cells are capable of anchorage-independent proliferation (Baserga, 1997). We therefore reasoned that conventional in vitro growth of ET cells as adherent monolayers might be expected to activate a number of signaling pathways secondary to phenomena such as cell-plastic adhesion and cell-spreading, that are not actually representative of in vivo tumor growth. Several studies have indicated that Figure 8 Primary Ewing tumors express activated ERK1/2 and AKT and variable levels of cyclin D1. Total protein lysates were obtained from 7 primary ET samples as detailed in Materials and methods. Western blots for expression of P-ERK1/2, P-AKT(Ser473), P-GSK3b(Ser 9) and cyclin D1 were performed as for ET cell lines, and show patterns similar to ET spheroid cultures. Monolayer (ML) and spheroid (Sph) cell lysates from TC32 cells that had been stimulated for 3 h with serum are shown for comparison anchorage-independent survival and proliferation of tumor cells are dependent on cell ± cell adhesion which is mimicked when tumor cells form multi-cellular spheroids (reviewed in Bates et al. (2000) ; Santini et al. (2000) ; Santini and Rainaldi (1999) ). We therefore cultured ET cell lines on agar-coated plates and found that they spontaneously form multi-cellular spheroids. Stable spheroids demonstrated numerous similarities to primary ET including small round cell morphology, a marked increase in well-developed cell ± cell junctions evident ultra-structurally, and a proliferative index of approximately 10%. The proliferative rate for primary ET is estimated to be 7 ± 14% (de Alava et al., 2000; Mellin et al., 1989; Niggli et al., 1994; Scotlandi et al., 1995; Vollmer et al., 1989) . In contrast, proliferative rates were signi®cantly higher in monolayer cells. This prompted us to test whether there were dierences in ET cell growth signaling in spheroid versus monolayer cultures. We found signi®cant variation in cyclin D1 expression as well as in RAS ± RAF ± MEK ± ERK1/2 and PI3K ± AKT signaling pathways between the two culture techniques. Whereas monolayers showed constitutively high level expression of cyclin D1 and serumdependent activation of ERK1/2 and AKT, transfer of cells to anchorage-independent cultures resulted in immediate loss of cyclin D1 protein, sustained serumindependent activation of ERK1/2, and transient serumindependent AKT activation. The pattern of cyclin D1 expression as well as ERK1/2 and AKT phosphorylation observed in a set of primary Ewing tumors mimicked that of ET spheroids, suggesting that primary ET growth signaling in vivo may be better represented in vitro by anchorage-independent spheroids.
Aberrant activation of both the RAS ± ERK1/2 and PI3K ± AKT pathways is associated with cellular transformation (Kopnin, 2000) . A well-established link exists between RAS activation and induction of cyclin D1 transcription in dierent cell types (ConnellCrowley et al., 1998; Liu et al., 1995; Robles et al., 1998; Rodriguez-Puebla et al., 1999) . Paradoxically, we did not ®nd a correlation between constitutive activation of ERK1/2 and cyclin D1 expression in ET spheroids. Rather, cyclin D1 protein expression in spheroids appeared to be dependent on cell ± cell adhesion and serum stimulation in a largely ERK1/2 independent manner. Blockade of MEK1 had negligible eects on cyclin D1 protein levels and proliferation rates and no eect on cyclin D1 mRNA expression. These results indicate that cyclin D1 expression and cell cycle progression are regulated dierently in adherent and anchorage-independent settings and may not be critically dependent on ERK activation. This was corroborated by examination of a set of primary Ewing tumors, which demonstrated high levels of ERK1/2 activation that also did not correlate with levels of cyclin D1 expression. It is conceivable that adhesion of ET cells to plastic induces cyclin D1 expression via alternate pathways to those mediated by cell ± cell adhesion in ET spheroids or primary tumors. One possibility is that the cell shape changes induced by adherence of ET cells to plastic facilitate constitutive cyclin D1 expression and cellular proliferation by activating proteins such as Rho or Rac (Shields et al., 2000; Tapon and Hall, 1997) and p125 FAK (Hanks and Polte, 1997) . Our results are in contrast to those of Silvany et al., who found that ERK1/2 activation was constitutive in cells transformed by EWS-FLI1, and that MEK1 inhibition blocked soft agar colony formation of these cells (Silvany et al., 2000) . However, these studies were performed using murine NIH3T3 cells expressing EWS-FLI1 rather than human ET cells, and the observed variations might be cell type speci®c.
PI3K inhibition of monolayer or spheroid ET cells resulted in virtually complete loss of cyclin D1 protein expression and a marked reduction in proliferative rates. Consistent with these ®ndings, AKT phosphorylation was readily detectable in six of seven primary ET samples and appeared to correlate with cyclin D1 expression. Muise-Helmericks et al. (1998) have reported that cyclin D1 mRNA translation is controlled via a PI3K ± AKT dependent pathway in breast and colon carcinoma cell lines. We have observed that the down-regulation of cyclin D1 in response to PI3K inhibition in ET cells is also post-transcriptional. It is known that GSK3b enhances cyclin D1 protein phosphorylation and degradation (Diehl et al., 1998; Shao et al., 2000) , and that activation of AKT inhibits this function by phosphorylating GSK3b at serine residue 9 (Cross et al., 1995; van Weeren et al., 1998) . We found no dierences in the phosphorylation status of GSK3b(Ser9) in ET spheroids and monolayers, even when cyclin D1 levels were dramatically dierent. This suggests that the post-transcriptional regulation of cyclin D1 in ET may not be mediated by GSK3b(Ser9) phosphorylation and other possibilities need to be explored such as alternative phosphorylation sites or dierences in subcellular localization. Also not ruled out by our observations is the possibility that cyclin D1 protein expression in ET cells is mediated, at least in part, by a PI3K-dependent but AKT-independent mechanism. More studies are needed to rigorously test this possibility and to determine what targets of PI3K other than AKT might be involved in cyclin D1 regulation in ET cells.
PI3K blockade in monolayer cells was also associated with constitutive activation of ERK1/2. It is becoming increasingly apparent that the PI3K ± AKT and RAS ± RAF1 ± MEK ± ERK pathways are integrally linked (reviewed in Scheid and Woodgett, 2000) . In fact, several recent studies have demonstrated negative regulation of RAF1 through phosphorylation by AKT (Rommel et al., 1999; Zimmermann and Moelling, 1999) and MEK-induced cyclin D1 expression and cell cycle entry in NIH3T3 cells requires concomitant PI3K signaling (Treinies et al., 1999) . It is well established that constitutive expression of RAS can induce apoptosis or cell cycle arrest (reviewed in Roovers and Assoian, 2000) . An emerging model is that unless the PI3K-AKT pathway is activated in parallel, high RAS activity will lead to cell cycle arrest or apoptosis rather than proliferation (Gille and Downward, 1999; Scheid and Woodgett, 2000; Treinies et al., 1999) . It is therefore possible that the observed eect of PI3K on cyclin D1 regulation in ET cells is secondary to suppression of RAF1 to a level where ERK1/2 activation induces cell cycle progression. In this scenario, PI3K inhibition of ET cells would lead to increased ERK1/2 activation (as observed), which would in turn precipitate cell cycle arrest rather than progression. Again, our results support the need for further study into the PI3K targets that regulate cyclin D1 levels in ET.
One well-established function of AKT is to act as a survival factor (Dudek et al., 1997) . We found that activation of AKT in monolayer TC32 cells was serumdependent, but that transfer of cells to suspension cultures led to immediate serum-independent AKT activation. This was transient, with AKT activation becoming serum-dependent once stable spheroids had formed. It is therefore possible that transient activation of AKT allows cells to survive until they can clump and form the cell ± cell junctions that are critical for continued survival and cell cycle progression (Bates et al., 2000; Santini et al., 2000) . Wong et al. (2001) have shown that transformed cells which overexpress the antiapoptotic protein Bcl-2 have a greater propensity for the formation of lung metastases, presumably because they can evade apoptosis long enough to allow successful implantation. Activation of the AKT pathway may be an important mechanism facilitating survival and metastasis of non-adherent ET cells in vivo.
In conclusion, our results indicate that growth rates and several physical and biochemical characteristics of spheroid ET cells closely mimic those of primary Ewing tumors. Therefore at least some aspects of in vivo ET cell proliferation may be better represented in spheroid cultures compared to conventional monolayer cultures. However, it must be cautioned that the variability observed in ERK1/2 MAP kinase and PI3K ± AKT activation in dierent primary tumors preclude de®nitive statements about the contribution of each pathway to ET growth in vivo. In spite of this, we believe the trends observed warrant the further evaluation of anchorage-independent spheroids as in vitro models of primary ET. At least some of the dierences between monolayer and spheroid cells likely occur as a direct consequence of cell ± cell adhesion involving as yet undetermined adhesion molecules. These molecules may initiate signal transduction cascades such as the PI3K ± AKT pathway to ensure survival and proliferation of the tumor cells in their anchorage-independent milieu. The role of EWS-FLI1 in cyclin D1 regulation in ET cells also requires further investigation. Treatment of ET cells with EWS-FLI1 antisense results in G1 arrest and reduced proliferation (Kovar et al., 1996; Tanaka et al., 1997) , and Silvany et al. (2000) have observed that ERK1/2 activation is dependent on the ability of EWS-FLI1 to translocate to the nucleus. We are currently investigating whether subcellular localization of EWS-FLI1 varies between ET cells grown in suspension or as adherent monolayers. It will also be interesting to assess whether regulation of cyclin D1 in ET is integrally linked to the IGFI receptor and its downstream activation of PI3K (Kulik et al., 1997) . Given their increased sensitivity to mitogen withdrawal, it is probable that ET cells grown in suspension have an increased dependency on autocrine growth pathways such as those mediated by IGFI and GRP. Such key dierences in anchorage independent growth signaling pathways will need to be considered as novel pathway-targeted biologic therapies for Ewing tumors are developed.
Materials and methods
Cells and cell culture TC32, 5838 and A4573 cells were kindly provided by Dr Tim Triche, Children's Hospital Los Angeles, and were grown in 5% CO 2 in RPMI medium supplemented with 15% fetal bovine serum, 2 mM glutamine and antibiotic-antimycotic (GIBCO ± BRL, Life Technologies, Burlington). Monolayers were grown in untreated tissue culture dishes and were subjected to serum withdrawal and kinase inhibitors while in logarithmic growth phase. Con¯uent monolayers were trypsinized, resuspended as single cells, and replated on tissue culture dishes that had been coated with 1.4% agar for anchorage independent suspension cultures. Suspended cells were collected at intervals up to 24 h post-suspension for time course studies. After 48 h in suspension, stable spheroids were separated from single and dead cells by low speed (500 r.p.m.) centrifugation for 3 min and replated in new media on fresh agar-coated plates. Starvation of both monolayer and spheroid cells was accomplished by replacing the high-serum (15% FBS) media with serum-free (0.25% FBS) media for 20 ± 24 h prior to harvesting of cells or serum stimulation. Harvested cells were subsequently analysed for protein and RNA expression as described below.
Primary tumor specimens
Primary tumor samples were obtained from the tumor bank at Children's and Women's Health Centre of British Columbia. All samples were obtained prior to therapy and were con®rmed to express EWS-FLI1 gene fusions by reverse-transcriptase PCR. For immunohistochemical studies, formalin-®xed paran embedded samples were sectioned and processed as below. Fresh-frozen tissue samples embedded in OCT-freeze media and stored at 7708C were used for total protein lysates and Western blot analysis.
Immunohistochemistry and electron microscopy TC32 monolayer cells were washed and removed from culture plates by vigorous washing with phosphate buered saline (PBS). Spheroid cells were washed in PBS and then both monolayer and spheroid cells were pelleted, ®xed in formalin and embedded in paran as per standard protocols. Stored paran blocks of primary Ewing tumor biopsies were used for comparison. Histologic and immunohistochemical analysis was done on 4 mM sections of tissue/cell blocks. Morphology of cells was examined following staining with hematoxylin and eosin. Immunostaining with the PCNA antibody (BD Transduction Labs, Mississauga, Ontario, Canada) was performed following the manufacturer's instructions using a three-step streptavidin-biotin peroxidase method, with 3-amino-9-ethylcarbazole as the chromogen. Electron microscopy of primary tumor specimens and TC32 cells was done using standard procedures after cells were ®xed in 3% glutaraldehyde.
BrdU proliferation assays
Stable TC32 spheroids and logarithmic growth phase monolayers were starved in serum-free media for 24 h to synchronize cells as much as possible. Media was then changed to fresh media containing 15% FBS and 100 mM bromo-deoxyuridine (BrdU; Sigma) and cells allowed to grow for a subsequent 20 h. Following the 20 h incubation, cells were pelleted, formalin ®xed and embedded in paran as per standard protocols. Immunostaining with an anti-BrdU antibody (Sigma) was performed following the manufacturer's instructions. All conditions were repeated in triplicate and the percentage of BrdU positive cells was calculated by counting cells in ®ve representative high-power ®elds for each condition (approx. 200 ± 400 cells/hpf).
Cell cycle analysis by FACS
TC32 monolayer and spheroid cells were resuspended in PBS and vortexed to break apart cell clumps. Cells were then ®xed in 70% ethanol, treated with 100 mg/ml RNase, stained with 50 mg/ml propidium iodide, and live cells analysed for DNA content using the FACSCalibur Flow cytometry system with CellQuest and Mod®t LT analytic software (Becton Dickinson, San Jose).
Protein Lysate preparation and immunoblotting
ET cell lines were rinsed once in PBS and then lysed in phosphorylation solubilization buer (50 mM HEPES, 100 mM NaF, 10 mM Na 4 P 2 O 7 , 2 mM Na 3 VO 4 , 2 mM EDTA, 2 mM NaMoO 4 2H 2 O, 1% Triton-X) containing protease inhibitors (leupeptin 10 mg/ml, aprotinin 10 mg/ml, and PMSF 250 mM) and 0.01% H 2 O 2 . Primary tumor and xenograft lysates were obtained by cutting sections of frozen tissue directly into lysis buer. Homogenization/solubilization was accomplished by high-speed vortexing and passage of tissues through a 21-gauge needle followed by incubation on ice for a minimum of 30 min. Following solubilization, protein concentrations were determined and standardized using the DC Bio-Rad Protein assay kit (Bio-Rad Laboratories, CA, USA) and 30 mg of total protein was resolved by 10 ± 15% SDS ± PAGE. Following electrophoretic transfer to Immobilon-P PVDF membranes (Millipore, MA, USA), Western blot analysis was performed using the indicated antibodies at dilutions according to the manufacturer's instructions. Secondary anti-mouse and anti-rabbit antibodies conjugated to horseradish peroxidase were obtained from BD Transduction Labs (Mississauga, Ontario, Canada) and blotted proteins were visualized using enhanced chemiluminescence (Amersham Pharmacia, Quebec, Canada). Phospho-ERK1/2, total-ERK, phospho-AKT, total-AKT, phospho-GSK3b, and Grb2 antibodies were obtained from New England Biolabs (NEB/Cell Signaling, Mississauga, Ontario, Canada). The antibody to cyclin D1 was obtained from Upstate Biotechnology (Lake Placid, NY, USA).
Kinase inhibitor studies
Starved TC32 cells were treated with either the MEK1 inhibitor U0126 (Calbiochem, San Diego, CA, USA) at 20 mM for 30 min, the PI3K inhibitor LY294002 (Calbiochem) or wortmannin (Sigma) at 50 mM or 200 nM, respectively, for 3 h, or an equivalent volume dimethylsulfoxide (DMSO) vehicle control. Following inhibitor treatment cells were harvested without serum stimulation or were stimulated with serum for 30 min or 3 h prior to lysis. Total protein lysates and immunoblotting were carried out as above. To assess the eects of MEK and PI3K inhibition on cell proliferation, 20 mM U0126 or 50 mM LY294002 were added to respective cultures in the presence of BrdU and serum for 20 h and then cells collected for immunohistochemistry as described above.
Northern analysis
Northern blotting was performed according to standard methods (Sambrook et al., 1989) . Total RNA was extracted from TC32 monolayer and spheroid cells grown and treated as detailed above using one-step Trizol extraction (Gibco ± BRL, Life Technologies). Ten micrograms of denatured total RNA was blotted and probed with 100 ng of [a-32 P]dCTP (Amersham)-labeled cDNA probes. The cyclin D1 probe was provided by Dr Tim Triche and equal loading was con®rmed using a cDNA probe for EWS provided by Dr Chris Denny, UCLA.
